The human immunodeficiency virus-1 protease inhibitor nelfinavir impairs proteasome activity and inhibits the proliferation of multiple myeloma cells in vitro and in vivo
about
Role of endoplasmic reticulum stress in drug-induced toxicityA conceptually new treatment approach for relapsed glioblastoma: coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma CareNelfinavir and other protease inhibitors in cancer: mechanisms involved in anticancer activityInsights into the broad cellular effects of nelfinavir and the HIV protease inhibitors supporting their role in cancer treatment and preventionA phase I trial of the HIV protease inhibitor nelfinavir in adults with solid tumorsEfficacy of nelfinavir as monotherapy in refractory adenoid cystic carcinoma: Results of a phase II clinical trialMarketed nonsteroidal anti-inflammatory agents, antihypertensives, and human immunodeficiency virus protease inhibitors: as-yet-unused weapons of the oncologists' arsenal.Broad targeting of resistance to apoptosis in cancer.Nelfinavir augments proteasome inhibition by bortezomib in myeloma cells and overcomes bortezomib and carfilzomib resistance.Treatment with the HIV protease inhibitor nelfinavir triggers the unfolded protein response and may overcome proteasome inhibitor resistance of multiple myeloma in combination with bortezomib: a phase I trial (SAKK 65/08).Is nelfinavir exposure associated with cancer incidence in HIV-positive individuals?Sequence-specific alterations of epitope production by HIV protease inhibitors.Endoplasmic reticulum stress and cell death in mTORC1-overactive cells is induced by nelfinavir and enhanced by chloroquine.HIV-protease inhibitors for the treatment of cancer: Repositioning HIV protease inhibitors while developing more potent NO-hybridized derivatives?Amprenavir inhibits the migration in human hepatocarcinoma cell and the growth of xenografts.The Antiretroviral Agent Nelfinavir Mesylate: A Potential Therapy for Systemic Sclerosis.The Impact of Human Papilloma Viruses, Matrix Metallo-Proteinases and HIV Protease Inhibitors on the Onset and Progression of Uterine Cervix Epithelial Tumors: A Review of Preclinical and Clinical Studies.
P2860
Q26765518-8CDBBA17-A469-4A5F-8A19-5FB47E142CE0Q26851160-087119D3-8FFE-4D04-9439-1916E558C64FQ28083142-7C5F052D-EC22-4E4E-87B0-EBBAF61541F9Q33642284-FCBFAAE7-C67D-4CB9-8465-0E49CAB92782Q34483485-A2844849-D7D1-475F-8F1D-FF2209A9F711Q34848294-00E35E8B-B4EF-4311-BE6C-8D5135F44E59Q35653603-6BE3B534-A4CE-4633-BA6F-14CC645969DFQ36483749-286864CC-F113-4A0C-916E-2DE9917791E1Q36736534-EE5CBF80-C3E2-4E99-83DA-A9118C77DB0DQ36750467-91C6DA7B-5D2A-4919-B393-06A36B7E91EFQ36957884-B4ABA3ED-1618-49B9-8A27-69CBDEC5EE85Q38710071-57DFB084-99DA-4749-9932-290CC74B344DQ38929614-2EC954FF-7FC2-44C0-BDCD-803F326D4330Q39015233-B064E7E0-2E4A-48EA-B4A8-64FDE8AC4975Q39298919-049CE3D9-36C7-4A4E-85E3-9EDB9BF21F09Q47756184-9080596C-9F7C-4FA7-A383-1C30892D9CF8Q54215275-91DFBF61-09B2-4730-9C8B-AFA994609F13
P2860
The human immunodeficiency virus-1 protease inhibitor nelfinavir impairs proteasome activity and inhibits the proliferation of multiple myeloma cells in vitro and in vivo
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
The human immunodeficiency vir ...... oma cells in vitro and in vivo
@en
The human immunodeficiency vir ...... ma cells in vitro and in vivo.
@nl
type
label
The human immunodeficiency vir ...... oma cells in vitro and in vivo
@en
The human immunodeficiency vir ...... ma cells in vitro and in vivo.
@nl
prefLabel
The human immunodeficiency vir ...... oma cells in vitro and in vivo
@en
The human immunodeficiency vir ...... ma cells in vitro and in vivo.
@nl
P2093
P2860
P1433
P1476
The human immunodeficiency vir ...... oma cells in vitro and in vivo
@en
P2093
Bertrand Arnulf
Camille Bono
Enguerran Mouly
Hélène Sauvageon
Jean-Christophe Bories
Jean-Paul Fermand
Lionel Galicier
Lionel Karlin
Stephanie Harel
Sylvaine Labaume
P2860
P304
P356
10.3324/HAEMATOL.2011.049981
P577
2012-01-22T00:00:00Z